Ten-year trends in prescribing of antiarrhythmic drugs in Australian primary care patients with atrial fibrillation.
Journal: Internal Medicine Journal
Published:
Abstract
Despite changes in antiarrhythmic drug (AAD) choice in patients with atrial fibrillation (AF), trends in AAD prescribing remain not investigated. We aimed to examine these changes using a nationwide Australian general practice data from 2009 to 2018. Over the 10 years, AAD prescribing in patients with AF decreased, which was mainly due to a reduction in the use of amiodarone, sotalol and digoxin. In contrast, the use of beta-blockers and flecainide increased.
Authors
Woldesellassie Bezabhe, Luke Bereznicki, Jan Radford, Mohammed Salahudeen, Edward Garrahy, Barbara Wimmer, Ivan Bindoff, Gregory Peterson
Relevant Conditions